Protective Mechanisms of a Metalloporphyrinic Peroxynitrite Decomposition Catalyst, WW85, in Rat Cardiac Transplants
- 1 July 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 314 (1) , 53-60
- https://doi.org/10.1124/jpet.105.083493
Abstract
Nitric oxide (NO) derived from inducible NO synthase has been implicated in cardiac rejection. However, little is known about the role of the reactive nitrogen species peroxynitrite. We examined the protective actions of a peroxynitrite decomposition catalyst, WW85, in an experimental model of acute cardiac rejection. Heterotopic, abdominal transplantation of rat donor hearts was performed. Groups included isografts, allografts, or allografts treated with WW85, cyclosporine, or cyclosporine + WW85. We determined graft survival, histological rejection, and graft function (by in situ sonomicrometry). Intragraft biochemical analysis of cytokines and proapoptotic and antiapoptotic gene expression using reverse transcriptase-polymerase chain reaction were determined. Treatment with WW85 or cyclosporine alone prolonged graft survival, improved graft function, and decreased histological rejection. Graft survival was further significantly (P < 0.001) enhanced by combination treatment. A decrease was also shown in nitrotyrosine, poly(ADP-ribose) polymerase (PARP) activation, and lipid peroxide formation by WW85 that was potentiated when given in combination with cyclosporine. Benefits could not be ascribed to changes in intragraft myeloperoxidase activity. Only combination therapy produced significant decreases in inflammatory cytokine gene expression, suggesting that WW85 acted primarily downstream of these stimuli. In general, WW85 had no direct action on expression of the proapoptotic gene, Fas ligand; however, WW85 given alone or with cyclosporine enhanced expression of antiapoptotic genes Bcl-2 and Bcl-xL. Collectively, these findings suggest a protective action of the peroxynitrite decomposition catalyst WW85 on graft rejection that is independent of any action on leukocyte sequestration and cytokine gene expression. Rather, effects seem to be downstream on decreased protein nitration, decreased lipid peroxidation, and decreased PARP activation.This publication has 32 references indexed in Scilit:
- Treatment with α-Phenyl-N-tert-butylnitrone, a Free Radical-Trapping Agent, Abrogates Inflammatory Cytokine Gene Expression during Alloimmune Activation in Rat Cardiac AllograftsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allograftsThe Journal of Heart and Lung Transplantation, 2004
- Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic ratsJournal of the American College of Cardiology, 2004
- Role of calcium and superoxide dismutase in sensitizing mitochondria to peroxynitrite-induced permeability transitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Critical role of reactive nitrogen species in lung ischemia–reperfusion injuryThe Journal of Heart and Lung Transplantation, 2003
- Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejectionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac DysfunctionCirculation, 2003
- Myeloperoxidase produces nitrating oxidants in vivoJournal of Clinical Investigation, 2002
- Attenuated Acute Cardiac Rejection in NOS2 −/− Recipients Correlates With Reduced ApoptosisCirculation, 1999
- Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophilsNature, 1998